Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colette DeJong

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
JAMA Internal Medicine|November 2, 2018
Continuing Problems With Financial Conflicts of Interest and Clinical Practice GuidelinesColette DeJong, Robert Steinbrook
JAMA Internal Medicine|June 11, 2019
Shining a Light on Industry Payments to Health Care Professionals Who Are Not PhysiciansColette DeJong, Robert Steinbrook
JAMA Internal Medicine|September 8, 2020
Inclusion Across the Lifespan in Cardiovascular Trials-A Long Road AheadColette DeJong, Kenneth Covinsky
JAMA|May 3, 2017
Reconsidering Physician-Pharmaceutical Industry RelationshipsColette DeJong, R Adams Dudley
JAMA Internal Medicine|August 25, 2020
Multivessel or Culprit Vessel-Only Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction and Cardiogenic Shock: Real-World Evidence in Support of CULPRIT-SHOCKColette DeJong, Rita F Redberg
JAMA Internal Medicine|March 10, 2020
Continuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Face of Kidney Disease Progression-Safe and Possibly Life SavingColette DeJong, Richard W Grant
JAMA Internal Medicine|April 30, 2020
The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No HarmColette DeJong, Robert M Wachter
JAMA Internal Medicine|April 2, 2019
Supplemental Security Income and the Health of Low-Income AdultsColette DeJong, Mitchell H Katz
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 3, 2021
Trends in the Use of Angiotensin-Converting Enzyme Inhibitor and Angiotensin-II Receptor Blocker Among United States Adults From 1999 to 2018Kosuke Inoue, Colette DeJong, Masaomi Nangaku
JAMA Internal Medicine|November 27, 2018
Electrocardiographic Harbingers of Ventricular Tachycardia Arrest-A Moment of PauseColette DeJong, Arvind Nishtala, Nora Goldschlager
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
JAMA Internal Medicine|November 2, 2018
Continuing Problems With Financial Conflicts of Interest and Clinical Practice GuidelinesColette DeJong, Robert Steinbrook
JAMA Internal Medicine|June 11, 2019
Shining a Light on Industry Payments to Health Care Professionals Who Are Not PhysiciansColette DeJong, Robert Steinbrook
JAMA Internal Medicine|September 8, 2020
Inclusion Across the Lifespan in Cardiovascular Trials-A Long Road AheadColette DeJong, Kenneth Covinsky
JAMA|May 3, 2017
Reconsidering Physician-Pharmaceutical Industry RelationshipsColette DeJong, R Adams Dudley
JAMA Internal Medicine|August 25, 2020
Multivessel or Culprit Vessel-Only Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction and Cardiogenic Shock: Real-World Evidence in Support of CULPRIT-SHOCKColette DeJong, Rita F Redberg
JAMA Internal Medicine|March 10, 2020
Continuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Face of Kidney Disease Progression-Safe and Possibly Life SavingColette DeJong, Richard W Grant
JAMA Internal Medicine|April 30, 2020
The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No HarmColette DeJong, Robert M Wachter
JAMA Internal Medicine|April 2, 2019
Supplemental Security Income and the Health of Low-Income AdultsColette DeJong, Mitchell H Katz
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 3, 2021
Trends in the Use of Angiotensin-Converting Enzyme Inhibitor and Angiotensin-II Receptor Blocker Among United States Adults From 1999 to 2018Kosuke Inoue, Colette DeJong, Masaomi Nangaku
JAMA Internal Medicine|November 27, 2018
Electrocardiographic Harbingers of Ventricular Tachycardia Arrest-A Moment of PauseColette DeJong, Arvind Nishtala, Nora Goldschlager
Pageof 5